register

News & Trends - MedTech & Diagnostics

ResMed and GE Healthcare to boost ventilator manufacturing for COVID-19 patient care

Health Industry Hub | March 30, 2020 |

MedTech News: Australia is seeking to dramatically boost stocks ventilators in intensive care units. The coronavirus crisis is placing immense pressure on the global availability of ventilators, which are needed respiratory support of critically ill patients.

GE Healthcare and ResMed have elevated efforts in manufacturing ventilators to support clinicians, governments and the broader healthcare community in the fight against COVID-19.

GE Healthcare and Ford Motor Company will work together to scale the production of ventilators, arming clinicians with medical equipment important in the treatment of COVID-19 patients. Through this collaboration, Ford will provide its technical and production expertise with the goal of manufacturing a simplified design of GE Healthcare’s existing ventilator. This new system would be built specifically to address urgent needs during the pandemic, equipped with the essential functions required to safely treat COVID-19 patients.

“We are encouraged by how quickly companies from across industries have mobilised to help address the growing challenge we collectively face from COVID-19,” said GE Healthcare president and CEO Kieran Murphy. “We are proud to bring our clinical and technical expertise to this collaboration with Ford, working together to serve unprecedented demand for this life-saving technology and support clinicians as they meet patient needs.”

Customer engagement during COVID-19. Fill the gap of reduced fieldforce activities. Health Industry Hub combines expertise in delivering digital health content and measuring engagement with 20+ years industry experience. Created by industry for industry. Contact us.

ResMed CEO Mick Farrell said “ResMed is taking every measure possible worldwide to maximise the production of ventilators, masks, and other respiratory devices. We are looking to double or triple the output of ventilators, and scale up ventilation mask production more than tenfold.

“I urge all of us to do our part to help reduce the spread of the coronavirus, whether that is self-quarantining, working from home, sheltering in place, or just staying healthy for our families, particularly the elderly and those with compromised immune systems.


News & Trends - Pharmaceuticals

Manoj Saxena - Bayer

Breaking the mold: Bayer GM on the future of pharma workplaces – Reimagining Healthcare Senior Leadership Series

Health Industry Hub | July 18, 2024 |

In the latest episode of the Reimagining Healthcare senior leadership series, Manoj Saxena, General Manager Pharmaceuticals ANZ at Bayer voiced […]

More


News & Trends - Pharmaceuticals

Matt Zeller, Country President of Novartis ANZ

Novartis Country President talks essentials in shaping the future of health policy: Reimagining Healthcare senior leadership series

Health Industry Hub | July 18, 2024 |

In this episode of the Reimagining Healthcare senior leadership series, Matt Zeller, Country President of Novartis ANZ, explores how health […]

More


Medical

First guidelines to stamp out rising scientific integrity issues in medical journals

First guidelines to stamp out rising scientific integrity issues in medical journals

Health Industry Hub | July 18, 2024 |

The number of retractions issued for scientific research articles in 2023 exceeded 10,000 – smashing annual records. To date, publishers […]

More


News & Trends - Pharmaceuticals

Gilead secures MSAC nod for CAR-T therapy

Gilead secures MSAC nod for CAR-T therapy

Health Industry Hub | July 18, 2024 |

Pharma News: Gilead Sciences welcomes the Medical Services Advisory Committee (MSAC) recommendation for public funding of Yescarta (axicabtagene ciloleucel) as […]

More


This content is copyright protected. Please subscribe to gain access.